ABSTRACT: Rotator cuff tendon tears are one of the most common shoulder pathologies, especially in the aging population. Due to a poor healing response and degenerative changes associated with aging, rotator cuff repair failure remains common. Although cell-based therapies to augment rotator cuff repair appear promising, it is unknown whether the success of such a therapy is age-dependent. We hypothesized that autologous cell therapy would improve tendon-to-bone healing across age groups, with autologous juvenile cells realizing the greatest benefit. In this study, juvenile, adult, and aged rats underwent bilateral supraspinatus tendon repair with augmentation of one shoulder with autologous tendon-derived cell-seeded polycaprolactone scaffolds. At 8 weeks, shoulders treated with cells in both juvenile and aged animals exhibited increased cellularity, increased collagen organization, and improved mechanical properties. No changes between treated and control limbs were seen in adult rats. These findings suggest that cell delivery during supraspinatus repair initiates earlier matrix remodeling in juvenile and aged animals. This may be due to the relative "equilibrium" of adult tendon tissue with regards to catabolic and anabolic processes, contrasted with actively growing juvenile tendons and degenerative aged tendons. This study demonstrates the potential for autologous cell-seeded scaffolds to improve repairs in both the juvenile and aged population. ß
Musculoskeletal injuries and conditions affect over 28 million Americans every year with an associated annual cost estimated at $254 billion. 1 Among these soft tissue injuries, rotator cuff tendon tears are one of the most common shoulder pathologies, especially in the aging population. 2 In fact, 25-50% of the asymptomatic population over the age of 50, and 60% of symptomatic patients over the age of 60, has a rotator cuff tear. [3] [4] [5] Although clinical research has improved surgical methods and rehabilitation schemes, rotator cuff repair failure remains common. 6, 7 This may be in part due to an aged tendon milieu that does not support a prompt and effective healing response. 8 Degenerative changes associated with aging can further impair successful healing. 9 Due to these challenges in successfully restoring rotator cuff function, the clinical need for regenerative therapies is of utmost importance. [10] [11] [12] Recent work has focused on local augmentation of the cellularity of the tendon-bone interface during healing, including injection of autologous bone marrowderived mesenchymal stem cells or the suturing of a patellar tendon-derived cell-seeded scaffold over the repair site. These treatments improved the quality of the cuff repair both clinically and in animal models. 13, 14 Implanting tendon-derived cells may be valuable for regeneration, as delivery of these cells would increase the number of cells within the injury environment whose matrix-production would result in tendon-specific material deposition and scar remodeling. 13 Moreover, due to the high prevalence of pathology within the long head of the biceps (LHB) concomitant with chronic rotator cuff tears, 15 the commonly performed LHB tenotomy or tenodesis could serve as an ideal source for autologous tendonderived cells for subsequent cell-based augmentation of repair of the rotator cuff itself. 15, 16 Similarities between biceps cells and rotator cuff tendon fibroblasts has been previously identified, further supporting the use of LHB-derived cells to assist with rotator cuff healing. 17 Successfully delivering cells during repair presents an additional challenge. A variety of synthetic and biological scaffolds have been developed to provide mechanical support and/or to deliver cells or biologic factors to the repair site. 18, 19 Many polymeric materials have been shown to be biocompatible, enabling cell attachment and proliferation, and are approved by the FDA for use in human medical applications. 20 Nanofibrous polymer scaffolds produced via electrospinning have been especially popular in tendon repair applications, as their mechanical properties can be easily tuned during scaffold production, and they are capable of directing organized tissue formation. 21, 22 Our recent study has shown that surgical implantation of a electrospun poly(e-caprolactone) (PCL) scaffold has no adverse effects on the repair of the rotator cuff tendon, 23 supporting the use of this material as a platform for cell or drug delivery.
Although cell-augmentation of tendon repair appears to be a promising new strategy, it is unknown whether the success of such therapy is age-dependent. In other autologous cell-based therapies, such as autologous chondrocyte implantation (ACI) for cartilage repair, numerous reports have shown a marked decline in cellular activity with aging. 24, 25 Therefore, the objective of this study was to determine the effects and mechanisms of action of autologous juvenile, adult, and aged tendon-derived cells delivered using aligned nanofibrous scaffolds on healing tissue properties in our rat model of augmented rotator cuff repair. 23 Our hypotheses were that (i) tendon-derived cell-seeded scaffolds would increase collagen and cell organization at the repair site compared to scaffold only controls, resulting in enhanced tendon-bone healing with improved mechanical properties; and that (ii) tendon-derived cells from juvenile rats would result in the greatest improvement of mechanical outcomes in cuff healing compared to adult or aged rats.
METHODS

Study Design
Approval for this study was obtained from the University of Pennsylvania Institutional Animal Care and Use Committee. A total of 60 male Fisher (F-344) rats were divided into three age groups: juvenile (4 weeks), adult (8 months) and aged animals (16 months). Aged animals were received from the National Institute on Aging (NIA) Aged Animal repository, and all others from Charles River. Animals were housed in a conventional facility with 12 h light/dark cycles and were fed standard chow and provided water ad libitum.
Surgical Procedure
All animals underwent bilateral transection of their supraspinatus tendons using sterile techniques. A single surgeon (TRM) performed all surgical procedures to ensure consistency. Animals were anesthetized with 5% isoflurane inhalation and maintained at 2-3% during surgery. The transected tendon was tagged with nonabsorbable suture for later identification and repair. Simultaneously, the intra-articular biceps tendon was harvested from each shoulder for cell isolation. Three weeks later, augmented supraspinatus repair was performed in which the right shoulder received a tendon-derived cell-seeded scaffold while the left shoulder received an acellular scaffold to serve as a cell-free control. As described previously, 23 with the arm in external rotation, a 2 cm skin incision was made followed by blunt dissection down to the rotator cuff musculature. The cuff was exposed, and the supraspinatus was identified by its prior tagging suture. The tendon was mobilized and the tagging suture was removed. The distal end of the supraspinatus tendon was captured with double ended 5-0 suture. Any fibrocartilage at the greater tuberosity footprint was removed using a bur (1/16 00 diameter). A 0.5 mm drill hole was made transversely in an anteriorposterior orientation through the proximal part of the humerus in adult and aged animals, which were similar in size. A similar hole was made in the smaller juvenile animals using the suture needle (Covidien CV-15 taper). One end of the supraspinatus tendon suture was passed through the bone tunnel and clamped to the opposite side. One end of the 3 Â 5 mm scaffold was sutured with a double ended horizontal mattress stitch and the suture was passed through the bone tunnel. The supraspinatus suture was then tied down, re-approximating the tendon to the proximal humerus insertion site. The scaffold was held in place over the tendon and the existing horizontal mattress was sutured in place to the distal end of the tendon. The scaffold was then sutured proximally at each corner with minimal tension. Scaffold/tendon excursion under the acromion was visualized before closure of the deltoid and skin. Buprenorphine (0.05 mg/kg) was provided pre-operatively and twice per day for the following 3 days. Animals were sacrificed 8 weeks after the second surgery via CO 2 inhalation, animals were randomized for assay, and tissues were frozen (for mechanical analysis, n ¼ 12) or fixed in formalin (for histologic analysis, n ¼ 7). The 8-week time point was chosen based on similar previous studies and evidence that this time scale allows for a typical healing response, including inflammatory, proliferative, and remodeling phases to occur. Although the tissue remains unorganized and biomechanically inferior to uninjured tendon, it allows for an examination of the healing process as a whole and how it was affected by our particular therapeutic approach. 8 One additional animal from each age group received scaffolds seeded with Qtracker labeled cells (labeled in suspension according to manufacturer's protocol, ThermoFisher Scientific, Waltham, MA) bilaterally for cell tracking; this animal was sacrificed 1 week after the second surgery. Scaffolds were still identifiable at the time of sacrifice.
Scaffold Preparation
Fiber-aligned nanofibrous scaffolds were fabricated using a custom electrospinning setup. 26, 27 Quantitative assessment of fiber alignment in scaffolds produced using the fabrication settings used in this work results in nanofibers that are >90% aligned within AE20˚of the prevailing fiber direction. 26 Briefly, a poly(e-caprolactone) (PCL) solution was prepared and extruded through a charged spinneret along a highvoltage gradient onto an electrically grounded rotating mandrel, where it collected to form the fiber-aligned mesh. Scaffolds were cut to 3 Â 5 mm size, disinfected and hydrated in a graded series of alcohol washes and sterile PBS prior to cell seeding. Minimal PCL degradation after 8 weeks in vivo is expected.
Cell Culture
Biceps tendon tendon-derived cells were harvested by morselizing explant tissue and allowing cell migration onto tissue culture surfaces over a 1-week period. Bilateral tendon tissues from each animal were pooled. Cells were expanded in a basal medium consisting of high glucose DMEM supplemented with penicillin/streptomycin/Fungizone and 10% fetal bovine serum, and split at confluence. At passage 2, cells from each donor were seeded onto a scaffold (3 Â 5 Â 0.5 mm) at a density of 2 Â 10 5 cells/scaffold. This seeding density was based on previous studies. 26 It was chosen to maximize cell attachment and coverage of the scaffold at time of implantation. Cells used for in vivo tracking were labeled in suspension with QTracker dots according to manufacturer's protocol. Cells were allowed to attach to and expand on the scaffold for 2 days in basal medium prior to surgical implantation.
Tendon Mechanical Testing
Biomechanical properties of the supraspinatus tendons were determined as previously described. [28] [29] [30] [31] Briefly, surrounding tissue was removed and the supraspinatus tendon with muscle and humeral head was excised via fine dissection.
TENDON REPAIR AUGMENTATION WITH AGE
The supraspinatus muscle and any non-loadbearing tissue were removed under a light microscope. Verhoeff stain lines were placed on the supraspinatus tendon for optical strain analysis, beginning at the insertion site of the tendon and then placed at 2, 4, and 8 mm proximally. The cross-sectional area of the supraspinatus was measured using a laser device. The humerus was then embedded in a holding fixture using polymethyl-methacrylate (PMMA). The holding fixture was inserted into a specially designed testing fixture. The proximal end of the tendon was held in a screw clamp lined with sandpaper. The specimen was immersed in a 37˚C PBS bath, preloaded to 0.1 N, preconditioned for 10 cycles from 0.1 N to 0.5 N at a rate of 3%/s, and held for 300 s. Immediately following, a stress relaxation test was performed by elongating the specimen to a strain of 5% at a rate of 5%/s followed by a 600 s relaxation period. After the tendon was returned to the initial displacement for 60 s, a ramp to failure was applied at a rate of 0.3%/s. Using the stain lines, strain was measured optically with a custom program. Along with load data from the materials testing system, stiffness, modulus, stress relaxation, ultimate load, ultimate stress, and ultimate strain were calculated.
Histology
Histological analysis was performed to assess cell shape, cellularity, glycosaminoglycan content, and collagen fiber organization at the injury site and midsubstance of the repaired supraspinatus tendon. At the time of sacrifice, supraspinatus-humerus units were immediately dissected, fixed in formalin, and processed using standard paraffin techniques. Coronal sections (7 mm thickness) were stained with hematoxylin and eosin (H&E) to assess cell shape, cellularity, and collagen fiber orientation or with Safranin O-Fast Green (SafO) to assess glycosaminoglycan content. Cell shape and cellularity were evaluated by three blinded graders, using a scale of 1-3 (1 ¼ low, 2 ¼ moderate, 3 ¼ high) for cellularity and 1-3 (1 ¼ spindle shaped, 2 ¼ mixed, 3 ¼ rounded) for cell shape. SafO staining was quantified using ImageJ. Regions of interest (ROIs) were color thresholded for Safranin-positive red staining and thresholded areas were quantified as a percentage of the ROI. Circular standard deviation of collagen fibers was determined from polarizing microscopy images and analysis with custom software as described previously. 28 Four to six ROIs were assessed for each sample for each histological technique. Representative ROIs were chosen from at least two sections on two to three slides selected from comparable depths through the tendon.
Immunohistochemistry
The distribution of ECM proteins was localized using immunohistochemical techniques. The same tissue specimens from histology were used and stained for collagens type I (Millipore, Darmstadt, Germany, AB755P, 1:200 dilution) and type III (Sigma-Aldrich, St. Louis, MO, C7805, 1:500 dilution). Proteins were visualized using DAB, making the antiobodyconjugate turn brown. Images were taken at 20Â magnification near the scar tissue (2-3 images per slide, n ¼ 3 slides per age groups per treatment), and representative images are shown.
Cell Tracking
Supraspinatus-humerus units from cell-tracking animals were immediately dissected after sacrifice, fixed in 4% paraformaldehyde, decalcified in 0.5 M EDTA (pH 7), soaked in sucrose, flash frozen in OCT embedding compound, and sectioned coronally to 10 mm thickness. Slides were counterstained with DAPI. Images were taken with a Nikon Eclipse 90i upright microscope (Melville, NY).
Statistics
A power analysis for rat supraspinatus tendon mechanical testing was performed. With an error probability of 0.05 and power of 0.8, the minimum sample size for mechanics is 11 animals and for polarized light collagen organization is 3. After confirming data normality and equal variance, tissue mechanics, SafO quantification, and polarized light analysis were assessed using two-way ANOVA with Bonferroni posthoc tests comparing acellular scaffold control and cell-seeded scaffold treatment within age groups. Histology scores were evaluated using a Mann-Whitney test. Significance was set at p < 0.05 and trends at p < 0.1.
RESULTS
Cell Culture and Delivery Spindle-shaped cells readily migrated from morselized biceps tendon tissue onto tissue culture surfaces within the first 4 days of culture (Fig. 1A) . Three animals (5%) failed to produce cells (n ¼ 2 from adult group, n ¼ 1 from aged group). All cells reached confluence in a 6-well plate within 10 days. Expanding cultures to P2 produced an average of 2. (Fig. 1B) . H&E and fluorescent imaging of consecutive sections confirmed the presence of delivered Qtracker-labeled cells in the shoulder 1 week after surgery (Fig. 1C and D) . Initial migration of cells into the surrounding tendon was observed. Similar to our previous findings, 23 gross appearance at the time of sacrifice revealed that the implanted scaffolds were maintained in situ without migration from the supraspinatus tendon during the study interval; conversely, scaffold attachment to the bone appeared to be disrupted in all samples due to the presence of scar tissue surrounding the implant. No donor site morbidity due to LHB harvest was identified by animal observation or gross shoulder morphology.
Tendon Mechanics
Eight weeks post-repair, elastic and viscoelastic mechanical properties improved in the cell-seeded scaffold groups in both juvenile and aged animals when compared to scaffold-only controls. Specifically, in cellseeded groups, stiffness and midsubstance modulus increased in juvenile animals, and midsubstance modulus increased in aged animals, with a trend toward an increase in stiffness ( Fig. 2A and B) . Maximum stress increased in aged animals (Fig. 2C) relative to acellular scaffold controls. No changes were seen in any parameter in adult animals. Scaffold-only repairs provided similar mechanical properties as seen in our preliminary study, supporting the use of PCL scaffolds in therapeutics. 
Tendon Histology and Immunohistochemistry
Implantation of cell-seeded scaffolds also improved histological parameters. Specifically, cellularity increased at the insertion in both juvenile and aged groups (Fig. 3A) . Additionally, cells were significantly more spindle-shaped in juvenile animals (insertion only, Fig. 3B ). No changes were seen in cellularity or cell shape in the midsubstance (data not shown). Cell delivery decreased SafO staining in aged animals (Fig. 4) , and increased collagen organization (decreased circular standard deviation) in both the insertion and midsubstance of aged animals, and in the insertion of juvenile animals (Fig. 5) . No changes were seen in any parameter in adult animals.
Changes in protein expression were observed with immunohistochemical staining. Compared with scaffold controls, collagen I was increased in juvenile and aged animals with cell delivery (Fig. 6, top panel) , while expression in adult animals appears similar regardless of treatment type. In contrast, collagen III decreased in aged animals with cell delivery, while adult animals displayed regions of very low expression levels regardless of treatment type (Fig. 6, bottom  panel) .
DISCUSSION
Results demonstrate that delivery of autologous tendon-derived cells to the healing supraspinatus is beneficial in juvenile and aged animals, with no apparent effect in adult animals. Previous studies demonstrated improvements in shoulder healing after the delivery of autologous mesenchymal stem cells or patellar tendon-derived cells 13, 14 ; however, the effects of a biceps tendon-derived cell-seeded graft had not yet been assessed, and autologous cell therapy had not yet been analyzed across a broad age range. We hypothesized that supplementing rotator cuff repair with a tendon-derived cell-seeded scaffold would improve mechanical properties via increased cellular activity and collagen organization at the repair site. Consistent with our hypothesis, tendon-bone healing was improved in juvenile and aged animal cohorts. As aged animals exhibit inferior tendon mechanical properties and healing potential, 7,32 a 44% increase in maximum stress with cell augmentation is a substantial improvement relative to control conditions. Coupled with up to threefold increases in tendon modulus and stiffness, the improvements in tendon mechanical strength for both aged and juvenile animals were striking. Increased numbers of cells at the insertion of treated animals demonstrates a more robust repair response, reflected in significant increases in collagen organization. Additionally, immunohistochemical analysis of collagen types revealed increases in collagen I in juvenile and aged animals with cell delivery, suggesting that delivered cells initiated beneficial matrix protein production. In contrast, collagen III and Safranin Opositive proteoglycans, which are associated with disorganized fibrous scar tissue, 8 both decreased in aged animals with cell delivery. These data suggest that matrix remodeling occurs more rapidly and results in improved collagen production and increased collagen alignment with cell-augmented repair.
While these findings support our first hypothesis, our second hypothesis was not substantiated. Surprisingly, both young and old animals benefitted similarly, yet no changes were seen in adult animals. We speculate that this may be because adult tendons are in relative "equilibrium" with regard to catabolic and anabolic processes, so additional cells likely only sustain regular repair mechanisms. Conversely, juvenile tendons are actively growing, with an increased rate of collagen production similar to that seen in injured animals. 33 In contrast, aged tendons exhibit diminished cell activity and matrix turnover. Many other aspects of the tendon milieu and metabolism are altered in young and old animals. Our data suggests decreased collagen III production during healing, regardless of treatment type, supporting the idea that matrix metabolism differs across age groups. Additionally, collagen crosslinking profiles differ greatly between juvenile, adult, and aged animals, with increased hydroxyproline production in young animals and a conversion to nonreducible crosslinks in senescent tissue. 34 Water and proteoglycan content as well as collagen fibril diameter also decrease with age. 35 Energy production mechanisms change with age, with aerobic glycolysis playing the major role in energy production in rabbit tendon cells up to 3 months, but tapering off completely by 1 year of age. 36 Overall, adult tendons represent a more homeostatic environment than that of juvenile or aged tendons. In the context of our study, the addition of a supplemental cell population to these "imbalanced" 14 In a case-controlled clinical study, injection of bone marrow derived mesenchymal stem cells into the tendon-bone interface also enhanced the rate of healing. A 10-year follow-up showed that these injections also decreased the incidence of subsequent ruptures over time. 13 However, the study size was relatively small, the retention of cells at the repair site was not investigated, and there were limited outcome measures. The age of bone marrow MSCs did not affect their repair ability in a rabbit model of patellar tendon healing, and although in a 37 Additionally, harvesting cells from bone marrow or from tendons in other joint spaces can lead to donor-site morbidities. 38, 39 Utilizing tissue that is frequently involved in the chronic rotator cuff tear pathology could minimize donor-site complications.
Our results did demonstrate that LHB tissues provide an abundant cell population for therapeutic application, regardless of age. Only three animals (5%) failed to yield sufficient cells from collected tissues. Gene expression and protein analyses of human biceps tendon-derived cells suggest that monolayer culture of primary cells does not affect cell phenotype until passage 4. 40 Similar results were seen in juvenile rabbit Achilles tenocytes, with dedifferentiation occurring after passage 3, 41 and in rabbit patellar tenocytes, with tendon cell markers maintained at similar levels to uncultured cells through passage 2.
14 These studies establish the capability of tenocytes to maintain their phenotype and production of key proteins such as type I collagen and tenascin-C after expansion. Therefore, cultured tendon-derived cells are an optimal cell candidate for an autologous tissue-engineering approach to enhancing tendon healing.
This study had several limitations. First, this study was performed in a quadruped animal model which does not replicate the human condition. However, the widely used rat rotator cuff model does have many anatomic similarities to the human shoulder, and this study included 3 weeks of a "chronic" supraspinatus tear, allowing tendon retraction that typifies the clinical condition more than typical acute tear models. This model can provide useful information for directing future large-animal or clinical studies. Second, although the autologous cells utilized in this study were harvested from the biceps tendon, no analysis was performed to confirm a tenocyte phenotype. Additionally, they were harvested from healthy biceps tissue as opposed to pathologic tissue likely to be present in the clinical condition. Unfortunately, little is known regarding the effects of LHB pathology on its cellular constituents. A recent study showed no significant differences in histological scoring (including analysis of tenocyte morphology, ground substance, fiber organization, and vascularity) between human LHB tendons from rotator cuff-deficient shoulders as compared with rotator cuff-intact shoulders. 42 Overall, this cell population has been insufficiently evaluated to speculate on how LHB pathology would affect our study. Also of note, many of our measured properties exhibited a high amount of variability. We surmise that these variations may be due to slight disparities in LHB dissection and consequent cell outgrowth, creating differences in the populations of delivered cells. Further studies will aim to characterize the cells phenotypically and investigate their mechanism of action in repair augmentation. Third, our findings were limited to the analysis of healing properties at one time point (8 weeks). Including additional groups for early and long-term analysis may provide further insight into the benefits of this cell therapy.
Finally, it should be noted that the current study required two separate surgical procedures, which is an acknowledged limitation. However, there are clinical scenarios where surgical debridement and/or bacterial cultures are required as part of an initial surgery, followed by a planned second surgery for the rotator cuff repair. In such a situation, a second surgery is part of the planned treatment, similar to an ACI procedure to treat cartilage damage. Additionally, this study raises the possibility for tissue banking of biceps tendon in the setting of rotator cuff surgery, given the high failure rate often necessitating a second surgery. Future studies will compare the use of tendon-derived cells to more easily accessible cell types such as skin fibroblasts, which would preclude the need for a second surgery.
In conclusion, results suggest that augmenting rotator cuff repair via an autologous tenocyte tissue engineering approach enhances healing. Increased collagen alignment, modulus, stiffness, and max stress signify an improvement in tendon-to-bone repair, which would be particularly advantageous for improving repair success in the aging population. Further research will investigate precise mechanisms of action by which these cell populations improve tissue healing.
